Recruiting Psoriatic Arthritis Studies in New York
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
The trial is an open-label randomized study that will examine whether switching to a selective IL23 inhibitor (guselkumab) is more effective than switching to a second TNFi (golimumab) among patients ...
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
The purpose of this study is to evaluate the pharmacokinetics (PK), efficacy, safety and immunogenicity of ustekinumab and guselkumab in active juvenile psoriatic arthritis (jPsA)....
About Psoriatic Arthritis Clinical Trials in New York
Psoriatic arthritis is a form of inflammatory arthritis that affects some people with psoriasis, causing joint pain, stiffness, and swelling. It can affect any joint and varies in severity. Treatment includes NSAIDs, DMARDs, biologics, and JAK inhibitors.
There are currently 2 psoriatic arthritis clinical trials recruiting participants in New York, NEW%20YORK. These studies are seeking a combined 198 participants. Research is being sponsored by University of Pennsylvania, Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Psoriatic Arthritis Clinical Trials in New York — FAQ
Are there psoriatic arthritis clinical trials in New York?
Yes, there are 2 psoriatic arthritis clinical trials currently recruiting in New York, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What psoriatic arthritis treatments are being tested?
The 2 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for psoriatic arthritis.
Data updated March 2, 2026 from ClinicalTrials.gov